No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ALGN240705P260000
- 20.93
- +1.97+10.39%
15min DelayTrading Jul 2 10:46 ET
20.93High20.93Low
20.93Open18.96Pre Close1 Volume2 Open Interest260.00Strike Price2.09KTurnover0.00%IV-0.86%PremiumJul 5, 2024Expiry Date22.97Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma10.56Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Press Release: Align Technology to Announce Second Quarter 2024 Results on July 24, 2024
Align Technology to Announce Second Quarter 2024 Results on July 24, 2024 TEMPE, Ariz.--(BUSINESS WIRE)--July 02, 2024-- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device compan
Align Technology to Announce Second Quarter 2024 Results on July 24, 2024
TEMPE, Ariz.--(BUSINESS WIRE)--Jul. 2, 2024-- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligne
Align Technology, Inc.'s (NASDAQ:ALGN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
It is hard to get excited after looking at Align Technology's (NASDAQ:ALGN) recent performance, when its stock has declined 23% over the past three months.
(ALGN) - Analyzing Align Tech's Short Interest
Align Tech's (NYSE:ALGN) short percent of float has risen 19.92% since its last report. The company recently reported that it has 1.84 million shares sold short, which is 3.13% of all regular shares t
Insulet Tops S&P 500 Growth Chart for Q2 as It Gains Market Share in the Diabetes Space
Align Technology Added as a New Short Idea at Hedgeye
Comments
Stocks to Watch
Nike Inc (NKE US) $Nike(NKE.US$
Daily Chart -[BEARISH ↘ **]Nike shaped a bearish wedge breakdown. We prefer to stay bearish for now, expecting price to do a pause below 81.20 resistance before shaping a fresh drop towards 64.00 support. Technical indicators are advocating for a bearish scenario.
Alternatively: A daily candlestick close above 81.20 resistance will open a recovery towards the next resistance at 93.50.
Monde...
Nike Inc (NKE US) $Nike(NKE.US$
Daily Chart -[BEARISH ↘ **]Nike shaped a bearish wedge breakdown. We prefer to stay bearish for now, expecting price to do a pause below 81.20 resistance before shaping a fresh drop towards 64.00 support. Technical indicators are advocating for a bearish scenario.
Alternatively: A daily candlestick close above 81.20 resistance will open a recovery towards the next resistance at 93.50.
Monde...
+3
26
5
Recent insider share sale at around US$300 raises caution. Despite some insider buying, the long-term outlook isn't positive. However, significant insider ownership suggests management's incentives align with shareholders.
Align Technology's falling ROCE trend is concerning. The stock's modest 18% gain over five years may reflect investor caution. Those seeking a multi-bagger might find better opportunities elsewhere.
The company's positive sales forecast, spurred by increased revenue from its Invisalign teeth-alignment system, resulted in a 10.3% surge in after-hours shares. This follows last year's demand concerns due to fewer dental visits and higher prices for essentials. The shutdown of competitor SmileDirectClub last month may have also boosted the optimistic outlook.
Read more
Cui Nyonya Kueh : uncle @soyabean89 ... fyi .
soyabean89 Cui Nyonya Kueh: Nike still got room to drop?!
brutal
Trader’s EdgeOP soyabean89: The bearish momentum on the Weekly chart and the Daily chart does look very strong.. - Isaac
12moon : It is interesting to hear from Trader's Edge,but it is risky to follow blindly. Weekly view is too speculative
Cui Nyonya Kueh : "This report is provided for informational and general circulation purposes only and should not be construed as an offer, solicitation, or recommendation for the purchase or sale of securities, futures, or other investment products. It does not take into consideration any particular needs of any person. This advertisement has not been reviewed by the Monetary Authority of Singapore."